Abstract
Get full access to this article
View all access options for this article.
References
1.Injury prevention and control: Opioid overdose. Data overview. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugoverdose/data/index.html. Accessed July 21, 2016.
2.Injury prevention and control: Opioid overdose. Prescription opioid overdose data. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugoverdose/data/overdose.html. Accessed July 21, 2016.
3.Timeline of selected FDA activities and significant events addressing opioid misuse and abuse. US Food and Drug Administration website. http://www.fda.gov/Drugs/Drug-Safety/InformationbyDrugClass/ucm338566.htm. Accessed July 21, 2016.
4.
Gabay M.
Prescription drug monitoring programs . Hosp Pharm. 2015 ; 50 (4 ): 277 –278 .
5.
Wheeler E.
Jones T.S.
Gilbert K.
Opioid overdose prevention programs providing naloxone to laypersons – United States, 2014 . MMWR Morb Mortal Wkly Rep. 2015 ; 64 (23 ): 631 –635 .
6.
Davis C.S.
Carr D.
Legal changes to increase access to naloxone for opioid overdose reversal in the United States . Drug Alcohol Depend. 2015 ; 157 : 112 –120 .